PRIMARY STUDY
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
Key Findings: In this in vitro study delta(9)-tetrahydrocannabivarin (THCV) activates CB2 receptors and reduced signs of inflammation and inflammatory pain in mice. This mechanism of action appears to be through CB1 and/or CB2 receptor activation.
Type of Study: Laboratory Study
Study Result: Positive
Study Location(s): United Kingdom
Year of Pub: 2021
Cannabinoids Studied: Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Cannabis Flower derived
Receptors Studied: CB1, CB2
